Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-031398

Executive Chairman disposed of 2,500,127 shares (other)

  • Executive Chairman acquired 207,001 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Samuel J Executive Chairman 2022-05-20 Other disposition −2,500,127 547,698 I
Reich Samuel J Executive Chairman 2022-05-20 Other acquisition +207,001 208,001 D
Loading xslF345X03/doc4.xml…